Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Yuval Raviv"'
Autor:
Alessio D. Nahmad, Yuval Raviv, Miriam Horovitz-Fried, Ilan Sofer, Tal Akriv, Daniel Nataf, Iris Dotan, Yaron Carmi, David Burstein, Yariv Wine, Itai Benhar, Adi Barzel
Publikováno v:
Nature Communications, Vol 11, Iss 1, Pp 1-10 (2020)
Chronic antiretroviral therapy does not eradicate HIV infection. Here, the authors describe a potentially one-shot alternative by engineering B cells to express anti-HIV antibodies and undergo memory retention, isotype switching and clonal expansion
Externí odkaz:
https://doaj.org/article/53cea78635c1437b9150abc735992dd8
Autor:
Or Kakhlon, Hilla Vaknin, Kumudesh Mishra, Jeevitha D’Souza, Monzer Marisat, Uri Sprecher, Shane Wald‐Altman, Anna Dukhovny, Yuval Raviv, Benny Da’adoosh, Hamutal Engel, Sandrine Benhamron, Keren Nitzan, Sahar Sweetat, Anna Permyakova, Anat Mordechai, Hasan Orhan Akman, Hanna Rosenmann, Alexander Lossos, Joseph Tam, Berge A. Minassian, Miguel Weil
Publikováno v:
EMBO Molecular Medicine, Vol 13, Iss 10, Pp n/a-n/a (2021)
Abstract This work employs adult polyglucosan body disease (APBD) models to explore the efficacy and mechanism of action of the polyglucosan‐reducing compound 144DG11. APBD is a glycogen storage disorder (GSD) caused by glycogen branching enzyme (G
Externí odkaz:
https://doaj.org/article/1a148de87c5d456f843b17754edc0627
Autor:
Shira Peleg Hasson, Dov Hershkovitz, Lyri Adar, Miriam Brezis, Eliya Shachar, Rona Aks, Lee Galmor, Yuval Raviv, Shira Ben Neriah, Ofer Merimsky, Edmond Sabo, Ido Wolf, Tamar Safra
Publikováno v:
Cancers, Vol 15, Iss 1, p 218 (2022)
Comprehensive genomic profiling (CGP) allows for the detection of driver alterations at high resolution, but the limited number of approved targeted therapies and their high costs have contributed to its limited clinical utilization. We retrospective
Externí odkaz:
https://doaj.org/article/dbb1ff823159438d8277e33524a58f13
Autor:
Roy Zucker, Yael Wolff-Sagy, Noga Ramot, Yuval Raviv, Gil Lavie, Doron Netzer, Ariel Hammerman, Ronen Arbel
Publikováno v:
Sexually Transmitted Diseases.
Publikováno v:
Sexually transmitted diseases. 50(1)
We herein report a case of an altered immunocompetent patient with atypical monkeypox presentations after being vaccinated with JYNNOES vaccine. The initial presentation was of acute bacterial paronychia. This incident suggests the need for individua
Publikováno v:
Nature Biotechnology
Autor:
Keren Nitzan, Hamutal Engel, Hanna Rosenmann, Miguel Weil, Shane Wald-Altman, Berge A. Minassian, Anna Dukhovny, Benny Da'adoosh, Or Kakhlon, Hilla Vaknin, Marisat M, Yuval Raviv, Alexander Lossos, Sprecher U, D'Souza J, Joseph Tam, Anna Permyakova, Kumudesh Mishra, Sandrine Benhamron
This work employs Adult Polyglucosan Body Disease (APBD) models to explore the efficacy and mechanism of action of 144DG11, a new polyglucosan-reducing lead compound discovered by a high-throughput screen (HTS). APBD is an adult onset glycogen storag
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::979d3460130598d2c8cbd497f6ec6f67
https://doi.org/10.1101/2021.03.18.436069
https://doi.org/10.1101/2021.03.18.436069
Autor:
Miriam Horovitz-Fried, Tal Akriv, Yariv Wine, Nahmad Ad, David Burstein, Daniel Nataf, Ilan Sofer, Itai Benhar, Adi Barzel, Yuval Raviv, Yaron Carmi, Iris Dotan
Publikováno v:
Nature Communications, Vol 11, Iss 1, Pp 1-10 (2020)
Nature Communications
Nature Communications
HIV viremia can be controlled by chronic antiretroviral therapy. As a potentially single-shot alternative, B cells engineered by CRISPR/Cas9 to express anti-HIV broadly neutralizing antibodies (bNAbs) are capable of secreting high antibody titers. He
Autor:
Yariv Wine, Horovitz-Fried M, Itai Benhar, Sofer I, David Burstein, Nahmad Ad, Yuval Raviv, Iris Dotan, Daniel Nataf, Adi Barzel, Tal Akriv
HIV viremia can be controlled by chronic antiretroviral therapy. As a potentially single-shot alternative, B cells engineered by CRISPR/Cas9 to express anti-HIV broadly neutralizing antibodies (bNAbs) were shown capable of secreting high antibody tit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::97f3d1ea20ff80f44338d7b69f0e1d21
Autor:
Miriam R. Brezis, T. Safra, Lee Galmor, Yuval Raviv, Shira Peleg Hasson, Lyri Adar, Dov Hershkovizh, Eliya Shachar
Publikováno v:
Journal of Clinical Oncology. 39:5553-5553
5553 Background: Ovarian cancer (OC) is the second most common gynecologic malignancy and the most common cause of gynecologic cancer mortality in the United States. Homologous recombination deficiency (HRD), including the BRCA mutations, are found i